Zuqing Su

Prof. Zuqing Su


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2025 in Cell Proliferation
Verified
Journal Article
Open access
ZSZuqing Su
Zuqing Su
YLYanlin Li
Yanlin Li
ZZZihao Zhou
Zihao Zhou
BFBing Feng
Bing Feng
HCHaiming Chen
Haiming Chen
GZGuang-Juan Zheng
Guang-Juan Zheng
Colorectal cancer (CRC) is one of the most common malignant tumours and is the second leading cause of cancer‐related mortality worldwide. Despite the availability of preventative, diagnostic and treatment methods including endoscopic treatment, surgical intervention, radiotherapy, biologics, salvage therapy and immunotherapy, the mortality rate associated with CRC remains alarming. Consequently, there is a pressing need to search for medicines for the treatment of CRC. Phytomedicines have been shown to suppress the proliferation and metastasis of CRC through various mechanisms, including immune regulation, modulation of gut microbiota, targeting of stem cells, macrophage polarisation, glycolysis, ferroptosis induction, modulation of extracellular vesicles, activation of mitochondria‐induced apoptosis, inflammation reduction, oxidative stress management and intervention of autophagy. Furthermore, numerous studies have reported the anti‐cancer and anti‐metastatic effects of various phytomedicines, including curcumin, resveratrol, berberine, shikonin, dihydroartemisinin, fucoidan, luteolin, andrographolide, piperine, kaempferol, emodin, cannabidiol, tanshinone IIA and evodiamine. In this review, we sort out the effects and mechanisms of phytomedicines on CRC and outline the major phytomedicines commonly used in CRC treatment. We hope that these phytomedicines may serve as promising drugs or important lead compounds for the management of CRC.

5 March 2025 in Cell Proliferation
Verified
Journal Article
Open access
ZYZeting Ye
Zeting Ye
YLYanlin Li
Yanlin Li
XYXiaolin Yang
Xiaolin Yang
CLChenglin Li
Chenglin Li
RYRui Yu
Rui Yu
ZSZuqing Su
Zuqing Su
Metabolic syndrome encompasses a cluster of predictive metabolic risk factors, including obesity, insulin resistance, dyslipidemia, hyperglycemia and hypertension. It is strongly associated with the development of type 2 diabetes and cardiovascular disease. Given the increasing morbidity and mortality associated with metabolic syndrome, along with the limited availability of drug treatments, it is high time to investigate the pathogenesis of this condition and explore potential pharmacotherapies. Macrophages, well‐known innate immune cells, play an essential role in maintaining tissue immune homeostasis and multiple physiological processes, including glucose and lipid metabolism, oxidative stress and inflammation. Emerging evidence indicates that the effects of macrophages in metabolic syndrome are linked to macrophage‐mediated metaflammation. Phytochemicals derived from natural plants have been shown to exert therapeutic effects on metabolic syndrome by modulating macrophage function. In this review, we sort out the role of macrophage‐mediated metaflammation in the pathogenesis of metabolic syndrome and summarise potential phytochemicals that target macrophages for the treatment of this condition.

5 August 2025 in Carbohydrate Polymers
Verified
Journal Article
Closed access
CHChen Haiming
Chen Haiming
LYLiao Yijing
Liao Yijing
TBTang Bin
Tang Bin
MXMa Xiaoyu
Ma Xiaoyu
LHLi Hailun
Li Hailun
CLChuanjian Lu
Chuanjian Lu

1 January 2024 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
LTLipeng Tang
Lipeng Tang
BZBowen Zhang
Bowen Zhang
GLGuanzhuo Li
Guanzhuo Li
XQXinmin Qiu
Xinmin Qiu
ZDZixin Dai
Zixin Dai
GZGuang-Juan Zheng
Guang-Juan Zheng
Tang L, et al. Ann Dermatol. 2024 May;36:e41. https://doi.org/10.5021/ad.23.118

28 September 2026 in Science of Traditional Chinese Medicine
Verified
Journal Article
Open access
HZHaixin Zhong
Haixin Zhong
XDXiangliang Deng
Xiangliang Deng
KYKexin Yang
Kexin Yang
BTBin Tang
Bin Tang
YYYujie Yang
Yujie Yang
HCHaiming Chen
Haiming Chen
Psoriasis is a chronic, immune-mediated inflammatory skin disease characterized by erythematous plaques covered with silvery scales and often accompanied by pruritus, burning sensations, and pain. It is a systemic inflammatory disorder associated with increased production of pro-inflammatory cytokines by immune cells. Dendritic cells (DCs), the most potent antigen-presenting cells in the immune system, play an important role in the pathogenesis of psoriasis. The limited efficacy of current therapeutic agents may be attributable, at least in part, to an incomplete understanding of pathogenesis or suboptimal therapeutic target selection. Therefore, investigations into DCs not only provide critical insights into the pathogenesis of psoriasis but also identify a promising therapeutic target for disease management. This article describes the phenotype and function of DCs and highlights several natural medicines that regulate the onset and progression of psoriasis by regulating DC maturation and proliferation. DCs, which play a pivotal role in immune regulation, are critically involved in the pathogenesis and progression of psoriasis. Natural medicines offer diverse and effective therapeutic options for patients with psoriasis, exerting their antipsoriatic effects primarily by modulating DC activation and function.